BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35447339)

  • 41. Elimination of cancer stem cells and reactivation of latent HIV-1 via AMPK activation: Common mechanism of action linking inhibition of tumorigenesis and the potential eradication of HIV-1.
    Finley J
    Med Hypotheses; 2017 Jul; 104():133-146. PubMed ID: 28673572
    [TBL] [Abstract][Full Text] [Related]  

  • 42. EMT, cancer stem cells and autophagy; The three main axes of metastasis.
    Babaei G; Aziz SG; Jaghi NZZ
    Biomed Pharmacother; 2021 Jan; 133():110909. PubMed ID: 33227701
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autophagy Regulation on Cancer Stem Cell Maintenance, Metastasis, and Therapy Resistance.
    Wang X; Lee J; Xie C
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053542
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of autophagy in breast cancer and breast cancer stem cells (Review).
    Han Y; Fan S; Qin T; Yang J; Sun Y; Lu Y; Mao J; Li L
    Int J Oncol; 2018 Apr; 52(4):1057-1070. PubMed ID: 29436618
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autophagy in cancer stem/progenitor cells.
    Lin YH; Huang YC; Chen LH; Chu PM
    Cancer Chemother Pharmacol; 2015 May; 75(5):879-86. PubMed ID: 25424280
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dual-Blocking of PI3K and mTOR Improves Chemotherapeutic Effects on SW620 Human Colorectal Cancer Stem Cells by Inducing Differentiation.
    Kim MJ; Koo JE; Han GY; Kim B; Lee YS; Ahn C; Kim CW
    J Korean Med Sci; 2016 Mar; 31(3):360-70. PubMed ID: 26955235
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Dual Role of Autophagy in Cancer Development and a Therapeutic Strategy for Cancer by Targeting Autophagy.
    Yun CW; Jeon J; Go G; Lee JH; Lee SH
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375363
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cancer stem cells: Road to therapeutic resistance and strategies to overcome resistance.
    Makena MR; Ranjan A; Thirumala V; Reddy AP
    Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165339. PubMed ID: 30481586
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Autophagy in stem and progenitor cells.
    Rodolfo C; Di Bartolomeo S; Cecconi F
    Cell Mol Life Sci; 2016 Feb; 73(3):475-96. PubMed ID: 26502349
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functions of autophagy in the tumor microenvironment and cancer metastasis.
    Mowers EE; Sharifi MN; Macleod KF
    FEBS J; 2018 May; 285(10):1751-1766. PubMed ID: 29356327
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Side population cells separated from A549 lung cancer cell line possess cancer stem cell-like properties and inhibition of autophagy potentiates the cytotoxic effect of cisplatin.
    Yang Y; Fan Y; Qi Y; Liu D; Wu K; Wen F; Zhao S
    Oncol Rep; 2015 Aug; 34(2):929-35. PubMed ID: 26081992
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
    Eun K; Ham SW; Kim H
    BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
    [TBL] [Abstract][Full Text] [Related]  

  • 54. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
    Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
    Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
    [No Abstract]   [Full Text] [Related]  

  • 55. A novel reporter construct for screening small molecule inhibitors that specifically target self-renewing cancer cells.
    Shanmugam G; Mohan A; Kumari K; Louis JM; Soumya Krishnan U; Balagopal PG; George NA; Sebastian P; Maliekal TT
    Exp Cell Res; 2019 Oct; 383(2):111551. PubMed ID: 31401066
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cancer cells stemness: A doorstep to targeted therapy.
    Prasad S; Ramachandran S; Gupta N; Kaushik I; Srivastava SK
    Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165424. PubMed ID: 30818002
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antioxidant Mechanisms and ROS-Related MicroRNAs in Cancer Stem Cells.
    Dando I; Cordani M; Dalla Pozza E; Biondani G; Donadelli M; Palmieri M
    Oxid Med Cell Longev; 2015; 2015():425708. PubMed ID: 26064420
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Abrus agglutinin stimulates BMP-2-dependent differentiation through autophagic degradation of β-catenin in colon cancer stem cells.
    Panda PK; Naik PP; Praharaj PP; Meher BR; Gupta PK; Verma RS; Maiti TK; Shanmugam MK; Chinnathambi A; Alharbi SA; Sethi G; Agarwal R; Bhutia SK
    Mol Carcinog; 2018 May; 57(5):664-677. PubMed ID: 29457276
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [MicroRNAs Regulation of Cancer Stem Cells].
    Zhang JP; Jia YS; Tong ZS
    Sheng Li Ke Xue Jin Zhan; 2015 Feb; 46(1):17-22. PubMed ID: 26103721
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting glutamine metabolism and autophagy: the combination for prostate cancer radiosensitization.
    Mukha A; Kahya U; Dubrovska A
    Autophagy; 2021 Nov; 17(11):3879-3881. PubMed ID: 34486482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.